| 嘉南藥理大學 |
2022 |
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
|
Sun, Hsin-Yun; Cheng, Chien-Yu; Lin, Chi-Ying; Yang, Chia-Jui; Lee, Nan-Yao; Liou, Bo-Huang; Tang, Hung-Jen; Liu, Yuang-Meng; Lee, Chun-Yuan; Chen, Tun-Chieh; Huang, Yi-Chia; Lee, Yuan-Ti; Tsai, Ming-Jui; Lu, Po-Liang; Tsai, Hung-Chin; Wang, Ning-Chi; Hung, Tung-Che; Cheng, Shu-Hsing; Hung, Chien-Ching |
| 臺大學術典藏 |
2022-05-25T05:47:44Z |
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
|
HSIN-YUN SUN; Cheng, Chien-Yu; Lin, Chi-Ying; Yang, Chia-Jui; Lee, Nan-Yao; Liou, Bo-Huang; Tang, Hung-Jen; Liu, Yuang-Meng; Lee, Chun-Yuan; Chen, Tun-Chieh; Huang, Yi-Chia; Lee, Yuan-Ti; Tsai, Ming-Jui; Lu, Po-Liang; Tsai, Hung-Chin; Wang, Ning-Chi; Hung, Tung-Che; Cheng, Shu-Hsing; Hung, Chien-Ching |
| 國立成功大學 |
2022 |
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
|
Sun, H.-Y.;Cheng, Cheng C.-Y.;Lin, C.-Y.;Yang, C.-J.;Lee, N.-Y.;Liou, B.-H.;Tang, H.-J.;Liu, Y.-M.;Lee, C.-Y.;Chen, T.-C.;Huang, Y.-C.;Lee, Y.-T.;Tsai, M.-J.;Lu, P.-L.;Tsai, H.-C.;Wang, N.-C.;Hung, T.-C.;Cheng, S.-H.;Hung, C.-C. |
| 臺大學術典藏 |
2022-02-22T05:34:11Z |
Real-world effectiveness of glecaprevir/pibrentasvir and ledipasvir/sofosbuvir for mixed genotype hepatitis C infection: A multicenter pooled analysis in Taiwan
|
Chiu W.-N.; Hung C.-H.; Lu S.-N.; Chen M.-Y.; Tung S.-Y.; Wei K.-L.; Lu C.-K.; CHIEN-HUNG CHEN; Hu T.-H.; Hu J.-H.; Chen W.-M.; Chang T.-S. |
| 臺大學術典藏 |
2022-02-23T02:12:22Z |
Real-world effectiveness of glecaprevir/pibrentasvir and ledipasvir/sofosbuvir for mixed genotype hepatitis C infection: A multicenter pooled analysis in Taiwan
|
Chiu W.-N.; Hung C.-H.; Lu S.-N.; Chen M.-Y.; Tung S.-Y.; Wei K.-L.; Lu C.-K.; CHIEN-HUNG CHEN; Hu T.-H.; Hu J.-H.; Chen W.-M.; Chang T.-S. |
| 國立成功大學 |
2021 |
Real-world effectiveness of hyperbaric oxygen therapy for delayed neuropsychiatric sequelae after carbon monoxide poisoning
|
Liao, S.-C.;Shao, Shao S.-C.;Yang, K.-J.;Yang, C.-C. |
| 臺大學術典藏 |
2019-07-26T06:32:02Z |
Real-world effectiveness of medications on survival in patients with COPD-heart failure overlap
|
Yang K.-Y.;Pau-Chung Chen;Su W.-J.;Su K.-C.;Chou K.-T.;Tsai Y.-H.;Perng D.-W.;Yang Y.-H.;Su V.Y.-F.; Su V.Y.-F.; Yang Y.-H.; Perng D.-W.; Tsai Y.-H.; Chou K.-T.; Su K.-C.; Su W.-J.; PAU-CHUNG CHEN; Yang K.-Y. |
| 臺大學術典藏 |
2022-03-31T02:38:31Z |
Real-world effectiveness of medications on survival in patients with COPD-heart failure overlap
|
Su V.Y.-F.; Yang Y.-H.; Perng D.-W.; Tsai Y.-H.; Chou K.-T.; Su K.-C.; Su W.-J.; PAU-CHUNG CHEN; Yang K.-Y. |
| 臺大學術典藏 |
2022-05-03T03:02:17Z |
Real-world effectiveness of second-line Afatinib versus chemotherapy for the treatment of advanced lung squamous cell carcinoma in immunotherapy-na?ve patients
|
Chen Y.-Y.; Chang S.-C.; Chang C.-Y.; Chang C.-F.; Lai Y.-C.; Wei Y.-F.; CHUNG-YU CHEN |
| 國家衛生研究院 |
2023-01-30 |
Real-world effectiveness of sorafenib versus lenvatinib combined with PD-1 inhibitors in unresectable hepatocellular carcinoma
|
Chiang, HC;Lee, YC;Chang, TT;Lin, YJ;Wu, HT;Wang, CT;Chen, CY;Chen, PJ;Hsieh, MT;Lin, SH;Chen, SH;Chuang, CH;Wu, IC;Hong, TC;Wu, JS;Han, MZ;Chen, WT;Chiang, CM;Hung, KK;Kuo, HY |
| 國立成功大學 |
2023-02 |
Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma
|
Chiang;Hsueh-Chien;Lee;Yang-Cheng;Chang;Ting-Tsung;Lin;Yih-Jyh;Wu;Hung-Tsung;Wang;Chung-Teng;Chen;Chiung-Yu;Chen;Po-Jun;Hsieh;Ming-Tsung;Lin;Sheng-Hsiang;Chen;Shang-Hung;Chuang;Chiao-Hsiung;Wu;I-Chin;Hong;Tzu-Chun;Wu;Juei-Seng;Han;Meng-Zhi;Chen;Wei-Ting;Chiang;Chien-Ming;Hung;Kuan-Kai;Kuo;Hsin-Yu |
| 中山醫學大學 |
2021 |
Real-world efficacy and safety of lorlatinib in treating advanced ALK-positive non-small cell lung cancer patients
|
Lee, PH; Chen, KC; Hsu, KH; Huang, YH; Tseng, JS; Yang, TY; Chang, GC |
| 國立成功大學 |
2020-12-29 |
Real-world efficacy of biological agents in moderate-to-severe plaque psoriasis: An analysis of 75 patients in Taiwan
|
Chen;Yu-Chen;Huang;Yi-Ting;Yang;Chao-Chun;Lai;Edward, Chia-Cheng;Liu;Cheng-Han;Hsu;Chao-Kai;Wong;Tak-Wah;Chao;Sheau-Chiou;Sheu;Hamm-Ming;Lee;Chaw-Ning |
| 國立成功大學 |
2015 |
Real-world evaluation of compliance and preference in Alzheimer's disease treatment
|
Pai, Ming-Chyi; Aref, Hany; Bassil, Nazem; Kandiah, Nagaendran; Lee, Jae-Hong; Srinivasan, A. V.; diTommaso, Shelley; Yuksel, Ozgur |
| 國立成功大學 |
2016 |
Real-world evaluation of compliance and preference in Alzheimer's disease treatment: an observational study in Taiwan
|
Lai, Tzu-Hsien; Wang, Wen-Fu; Yip, Bak-Sau; Yang, Yu-Wan; Peng, Giia-Sheun; Tsai, Shih-Jei; Liao, Yi-Chu; Pai, Ming-Chyi |
| 臺大學術典藏 |
2021-09-17T06:19:48Z |
Real-World Evaluation of Modern Adjuvant Radiotherapy in Women with Stage IB Endometrial Cancer
|
Chen, Jenny Ling-Yu; Huang, Chao-Yuan; YU-SEN HUANG; Hsu, Che-Yu; Lan, Keng-Hsueh; Shih, I-Lun; Cheng, Wen-Fang; Chen, Chi-An; BOR-CHING SHEU; Kuo, Sung-Hsin |
| 臺大學術典藏 |
2021-10-04T06:16:56Z |
Real-World Evaluation of Modern Adjuvant Radiotherapy in Women with Stage IB Endometrial Cancer
|
Chen, Jenny Ling-Yu; Huang, Chao-Yuan; YU-SEN HUANG; Hsu, Che-Yu; Lan, Keng-Hsueh; Shih, I-Lun; Cheng, Wen-Fang; CHI-AN CHEN; Sheu, Bor-Ching; Kuo, Sung-Hsin |
| 臺大學術典藏 |
2021-12-16T05:29:51Z |
Real-World Evaluation of Modern Adjuvant Radiotherapy in Women with Stage IB Endometrial Cancer
|
Chen, Jenny Ling-Yu; Huang, Chao-Yuan; YU-SEN HUANG; Hsu, Che-Yu; Lan, Keng-Hsueh; I-LUN SHIH; Cheng, Wen-Fang; Chen, Chi-An; Sheu, Bor-Ching; Kuo, Sung-Hsin |
| 臺大學術典藏 |
2021-09-17T06:58:51Z |
Real-World Evaluation of Modern Adjuvant Radiotherapy in Women with Stage IB Endometrial Cancer
|
Chen, Jenny Ling-Yu; Huang, Chao-Yuan; YU-SEN HUANG; Hsu, Che-Yu; Lan, Keng-Hsueh; Shih, I-Lun; WEN-FANG CHENG; Chen, Chi-An; Sheu, Bor-Ching; Kuo, Sung-Hsin |
| 國立成功大學 |
2021-01-12 |
Real-world evidence and optimization of vocal dysfunction in end-stage renal disease patients with secondary hyperparathyroidism
|
Chang;Geng-He;Chou;Fong-Fu;Tsai;Ming-Shao;Tsai;Yao-Te;Yang;Ming-Yu;Huang;Ethan;I;Su;Hui-Chen;Hsu;Cheng-Ming |
| 國立成功大學 |
2023 |
Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease inTaiwan: A Prospective Nationwide Registry (VIOLET) Study
|
Lin, W.-C.;Tai, W.-C.;Chang, Chang C.-H.;Tu, C.-H.;Feng, I.-C.;Shieh, M.-J.;Chung, Chung C.-S.;Yen, H.-H.;Chou, J.-W.;Wong, J.-M.;Liu, Y.-H.;Huang, T.-Y.;Chuang, Chuang C.-H.;Tsai, Tsai T.-J.;Chiang, F.-F.;Lu, C.-Y.;Hsu, W.-H.;Yu, F.-J.;Chao, T.-H.;Wu, D.-C.;Ho, A.-S.;Lin, H.-H.;Feng, C.-L.;Wu, K.-L.;Wong, M.-W.;Tung, C.-C.;Lin, C.-C.;Chen, Chen C.-C.;Hu, Hu H.-M.;Lu, Lu L.-S.;Wang, H.-S.;Wu, I.-C.;Kuo, H.-Y.;Wu, J.-F.;Shih, H.Y.;Ni, Y.-H.;Tang, S.-L.;Chen, P.-H.;Wei, S.-C. |
| 國家衛生研究院 |
2023-05 |
Real-world evidence of hyperbaric oxygen therapy on cardiovascular outcomes in patients with chronic osteomyelitis
|
Tai, CJ;Lu, CK;Lee, CY;Lee, SS;Yang, YH |
| 國立成功大學 |
2021 |
Real-world evidence of population differences in allopurinol-related severe cutaneous adverse reactions in East Asians: A population-based cohort study
|
Sato, T.;Cheng, Cheng C.-L.;Park, H.-W.;Kao, Yang Y.-H.;Yang, M.-S.;Fujita, M.;Kumagai, Y.;Tohkin, M.;Saito, Y.;Sai, K. |
| 臺大學術典藏 |
2021-01-28T01:06:14Z |
Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan
|
Kun-Huei Yeh;Yang T.-S.;Hsu T.-C.;Tzu-Liang Chen W.;Chen H.-H.;Teng H.-W.;Lin B.-W.;Kuan F.-C.;Chiang F.-F.;Duann C.-W.;Li Y.-S.;Lin M.-T.;Fiala-Buskies S.;Ducreux M.;Wang J.-Y.; KUN-HUEI YEH; Yang T.-S.; Hsu T.-C.; Tzu-Liang Chen W.; Chen H.-H.; Teng H.-W.; Lin B.-W.; Kuan F.-C.; Chiang F.-F.; Duann C.-W.; Li Y.-S.; Lin M.-T.; Fiala-Buskies S.; Ducreux M.; Wang J.-Y. |
| 臺大學術典藏 |
2021-01-18T09:12:10Z |
Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan
|
KUN-HUEI YEH; Yang, Tsai Sheng; Hsu, Tzu Chi; Tzu-Liang Chen, William; Chen, Hong Hwa; Teng, Hao Wei; Lin, Bo Wen; Kuan, Feng Che; Chiang, Feng Fan; Duann, Chi Wei; Li, Ying Shiuan; Lin, Meng Ting; Fiala-Buskies, Sabine; Ducreux, Michel; Wang, Jaw Yuan |
| 國立成功大學 |
2021 |
Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan
|
Yeh, K.-H.;Yang, T.-S.;Hsu, T.-C.;Tzu-Liang, Chen W.;Chen, H.-H.;Teng, H.-W.;Lin, B.-W.;Kuan, F.-C.;Chiang, F.-F.;Duann, C.-W.;Li, Y.-S.;Lin, M.-T.;Fiala-Buskies, S.;Ducreux, M.;Wang, J.-Y. |
| 臺大學術典藏 |
2020-11-11T08:29:15Z |
Real-world evidence on the safety and effectiveness of fingolimod in patients with multiple sclerosis from Taiwan
|
Yang C.-C.; Yang C.-C.;Ro L.-S.;Tsai N.-W.;Lin C.-C.;Huang W.-N.;Tsai C.-P.;Lin T.-S.;Jen-Jen Su;Huang C.-C.;Lyu R.-K.;Chen H.-H.;Lee W.-J.;Chen P.-L.;Yang A.; Ro L.-S.; Tsai N.-W.; Lin C.-C.; Huang W.-N.; Tsai C.-P.; Lin T.-S.; JEN-JEN SU; Huang C.-C.; Lyu R.-K.; Chen H.-H.; Lee W.-J.; Chen P.-L.; Yang A. |
| 臺大學術典藏 |
2021-12-02T07:32:18Z |
Real-world evidence on the safety and effectiveness of fingolimod in patients with multiple sclerosis from Taiwan
|
Yang C.-C.; Ro L.-S.; Tsai N.-W.; Lin C.-C.; Huang W.-N.; Tsai C.-P.; Lin T.-S.; JEN-JEN SU; Huang C.-C.; Lyu R.-K.; Chen H.-H.; Lee W.-J.; Chen P.-L.; Yang A. |
| 國立成功大學 |
2021 |
Real-world evidence on the safety and effectiveness of fingolimod in patients with multiple sclerosis from Taiwan
|
Yang, C.-C.;Ro, L.-S.;Tsai, N.-W.;Lin, C.-C.;Huang, W.-N.;Tsai, C.-P.;Lin, T.-S.;Su, J.-J.;Huang, C.-C.;Lyu, R.-K.;Chen, H.-H.;Lee, W.-J.;Chen, P.-L.;Yang, A. |
| 國家衛生研究院 |
2020-08-02 |
Real-world evidence on the use of benzodiazepine receptor agonists and the risk of venous thromboembolism
|
Chen, TY;Winkelman, JW;Mao, WC;Tzeng, NS;Kuo, TBJ;Yang, CCH;Tsai, HJ;Wu, CS |
| 臺大學術典藏 |
2020-11-04T09:17:05Z |
Real-world evidence on the use of benzodiazepine receptor agonists and the risk of venous thromboembolism
|
Chen T.-Y.; Winkelman J.W.; Mao W.-C.; Tzeng N.-S.; Kuo T.B.J.; Yang C.C.H.; Tsai H.-J.; CHI-SHIN WU |
| 臺大學術典藏 |
2018-09-10T18:06:04Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang, S.-K. and Hsieh, M.-S. and Lee, M.-R. and Keng, L.-T. and Ko, J.-C. and Shih, J.-Y.; MENG-RUI LEE; KENG LI-TA; JEN-CHUNG KO; SHENG-KAI LIANG; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-03-05T08:04:03Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.;Min-Shu Hsieh;Lee M.-R.;Keng L.-T.;Ko J.-C.;Shih J.-Y.; Liang S.-K.; MIN-SHU HSIEH; Lee M.-R.; Keng L.-T.; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-13T06:33:37Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Keng L.-T.;Ko J.-C.;Jin-Yuan Shih; Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; Ko J.-C.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2017 |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.; Hsieh M.-S.; MENG-RUI LEE; Keng L.-T.; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2021-01-08T03:40:20Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Shih J.-Y.; Ko J.-C.; Lee M.-R.; Keng L.-T.; Hsieh M.-S.; SHENG-KAI LIANG |
| 臺大學術典藏 |
2021-03-11T07:58:31Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; JEN-CHANG KO; Shih J.-Y. |
| 臺大學術典藏 |
2021-03-11T08:29:35Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; JEN-CHANG KO; Shih J.-Y. |
| 臺大學術典藏 |
2021-03-11T08:34:21Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Keng L.-T.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; Min-Shu Hsieh; MENG-RUI LEE; LI-TA KENG; JEN-CHANG KO; Jin-Yuan Shih |
| 臺大學術典藏 |
2021-09-17T05:56:07Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.; Hsieh M.-S.; Lee M.-R.; LI-TA KENG; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2021-10-04T07:15:44Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; JEN-CHANG KO; Shih J.-Y. |
| 臺大學術典藏 |
2021-01-08T02:56:48Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Li-Ta Keng;Ko J.-C.;Shih J.-Y.; Liang S.-K.; Hsieh M.-S.; Lee M.-R.; LI-TA KENG; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2021-09-17T02:51:01Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.; Hsieh M.-S.; MENG-RUI LEE; Keng L.-T.; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2021-09-17T03:21:19Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
SHENG-KAI LIANG; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; Ko J.-C.; Shih J.-Y. |
| 中山醫學大學 |
2021 |
Real-world experience of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B: a retrospective study
|
Su, PY; Su, WW; Hsu, YC; Huang, SP; Yen, HH |
| 國立成功大學 |
2023 |
Real-world experience on intravitreal dexamethasone implant in patients with macular edema scheduled to undergo cataract surgery
|
Lai, C.-C.;Kuo, S.-C. |
| 臺大學術典藏 |
2021-05-06T01:25:13Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; Sun H.-Y.; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; Cheng A.; Ko W.-C.; Cheng S.-H.; CHIEN-CHING HUNG; the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-16T08:36:11Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; Sun H.-Y.; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; ARISTINE CHENG; Ko W.-C.; Cheng S.-H.; Hung C.-C.; the Taiwan HIV Study Group |
| 國立成功大學 |
2021 |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou, B.-H.;Sun, H.-Y.;Yang, C.-J.;Syue, L.-S.;Lee, Y.-L.;Tang, H.-J.;Tsai, H.-C.;Lin, C.-Y.;Chen, T.-C.;Lee, C.-Y.;Huang, S.-H.;Liu, C.-W.;Lu, P.-L.;Lin, S.-P.;Wang, N.-C.;Cheng, A.;Ko, W.-C.;Cheng, S.-H.;Hung, C.-C.;Group, the Taiwan HIV Study |
| 嘉南藥理大學 |
2021 |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou, Bo-Huang; Sun, Hsin-Yun; Yang, Chia-Jui; Syue, Ling-Shan; Lee, Yu-Lin; Tang, Hung-Jen; Tsai, Hung-Chin; Lin, Chi-Ying; Chen, Tun-Chieh; Lee, Chun-Yuan; Huang, Sung-Hsi; Liu, Chia-Wei; Lu, Po-Liang; Lin, Shih-Ping; Wang, Ning-Chi; Cheng, Aristine; Ko, Wen-Chien; Cheng, Shu-Hsing; Hung, Chien-Ching |
